Intensity Therapeutics to Participate in the LD Micro Invitational XIV Conference April 8 – 9, 2024

April 2, 2024

https://www.prnewswire.com/news-releases/intensity-therapeutics-to-participate-in-the-ld-micro-invitational-xiv-conference-april-8—9-2024-302105441.html

SHELTON, Conn., April 2, 2024 /PRNewswire/ — Intensity Therapeutics, Inc. (Nasdaq: INTS), a late-stage clinical biotechnology company focused on the discovery and development of proprietary, novel immune-based intratumoral cancer therapies designed to kill tumors and increase immune system recognition of cancers, announces that Lewis H. Bender, Founder, President and Chief Executive Officer, will present a corporate overview at the LD Micro Invitational XIV 2024. The conference is being held on April 8 – 9, 2024 at the Sofitel Hotel in New York City.

Read more at prnewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.